Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California. The event will bring together industry leaders, clinicians, investors, and entrepreneurs to advance innovation in neurotechnology. As part of Octane’s Innovation Event Series, the forum aims to foster partnerships and accelerate the development of next-generation neurotechnology solutions.
The forum will feature keynote speaker Dr. Adnan Siddiqui, CEO and CMO of the Jacobs Institute, along with more than 30 expert speakers. These speakers will address emerging neurotech technologies, digital health innovation, brain-computer interfaces, and the evolving investment landscape. The event format includes innovation panels, investor-focused sessions, company presentations, and networking opportunities designed to facilitate collaboration across the neurotechnology sector.
Octane fosters a future-focused ecosystem of tech and medtech companies across Southern California by connecting people, resources, and capital. The organization’s mission is to drive innovation and growth by facilitating the exchange of ideas, knowledge, and resources that fuel the development of Southern California’s tech and medtech industries. Octane impacts the community through several initiatives, including LaunchPad, a top-performing accelerator; Octane Capital & Growth, a platform providing companies with capital and growth resources; Ignite Series, offering in-person and on-demand leading content and events; and Octane Foundation for Innovation, which focuses on advancing the mission while promoting diversity and inclusiveness. More information about Octane is available at https://www.octaneoc.org.
The Neuro Tech Forum 2026 represents a significant gathering for the neurotechnology industry, which is rapidly evolving with advancements in brain-computer interfaces and digital health. By convening key stakeholders, the event could accelerate the translation of research into practical solutions, potentially impacting healthcare, technology development, and investment trends. For entrepreneurs and startups, the forum offers visibility and networking opportunities that could lead to partnerships and funding. For investors, it provides insights into emerging technologies and market opportunities. For clinicians and researchers, it facilitates knowledge exchange on cutting-edge applications that could improve patient outcomes.
The broader implications of this event extend to global health and technology sectors, as neurotechnology holds promise for addressing neurological disorders, enhancing human capabilities, and driving economic growth. Events like the Neuro Tech Forum play a crucial role in shaping the future of this field by aligning resources and expertise. The press release was distributed via InvestorWire, a specialized communications platform that is part of the Dynamic Brand Portfolio at IBN, offering wire-grade press release syndication and other corporate communications solutions. Additional details about InvestorWire can be found at https://www.InvestorWire.com.
